Migliario Mario, Mergoni Giovanni, Vescovi Paolo, Martino Iolanda De, Alessio Manuela, Benzi Luca, Renò Filippo, Fusco Vittorio
Dental Clinic, Health Sciences Department, University of Eastern Piedmont "A. Avogadro", 28100, Novara, Italy.
Oral Medicine and Laser Surgery Unit, University Center of Dentistry, Department of Medicine and Surgery, University of Parma, 43121, Parma, Italy.
Dent J (Basel). 2017 Mar 16;5(1):13. doi: 10.3390/dj5010013.
Osteonecrosis of the jaws (ONJ) in osteoporosis patients has been defined as rare, but the number of reported cases is increasing. We report a case of delayed ONJ diagnosis in a patient, who was being treated with alendronate, developing bone alterations both in maxilla and in mandible. Underestimation of ONJ incidence and missed or delayed ONJ diagnosis in osteoporosis patients might derive from lack of awareness of health providers as well as from an ONJ definition that is too restricted. The more recent definition of medication-related osteonecrosis of the jaws (MRONJ) released in 2014 by the American Association of Oral Maxillofacial Surgeons (AAOMS) accept fistula, besides bone exposure, as a major sign of disease, but it seems to be insufficient since it excludes all cases of ONJ disease without bone exposure. A new MRONJ definition is needed to avoid missing or delayed diagnosis.
骨质疏松症患者颌骨骨坏死(ONJ)一直被定义为罕见病,但报告的病例数量正在增加。我们报告了一例接受阿仑膦酸盐治疗的患者ONJ诊断延迟的病例,该患者上颌骨和下颌骨均出现骨质改变。骨质疏松症患者中ONJ发病率的低估以及ONJ诊断的漏诊或延迟,可能源于医疗服务提供者认识不足以及ONJ定义过于局限。美国口腔颌面外科医师协会(AAOMS)2014年发布的与药物相关的颌骨骨坏死(MRONJ)的最新定义,除了骨暴露外,还将瘘管视为疾病的主要体征,但这似乎并不充分,因为它排除了所有无骨暴露的ONJ病例。需要一个新的MRONJ定义以避免漏诊或延迟诊断。